Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-021378

Chief Financial Officer sold 12,000 shares at $187.92 ($2,255,040)

  • Chief Financial Officer acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pizzie Nick · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-22 Exercise or conversion : show line 1 in the form 10b5-1 +12,000 $3.50 $42,000 54,588 D
2026-01-22 Sale : show line 2 in the form 10b5-1 −12,000 $187.92 $2,255,040 42,588 D
Open-market sales · 12,000 sh · avg $187.92 · $2,255,040

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −12,000 105,000 D
Loading xslF345X05/ownership.xml…